Department of Neurology, University Hospital Salzburg, Salzburg, Austria.
AJNR Am J Neuroradiol. 2013 Feb;34(2):366-72. doi: 10.3174/ajnr.A3195. Epub 2012 Jul 12.
Revascularization of large cerebral artery occlusion is the therapeutic goal in stroke therapy. Currently, many recanalization devices are in clinical use. This study compares the outcome parameters, efficacy, and safety of the new generation of stent-retriever devices with the well-established Merci retriever.
All patients who received endovascular mechanical recanalization therapy were prospectively registered. One hundred twenty-two patients were treated with either new stent retrievers, including the Trevo and Solitaire devices, or the Merci retriever system. Recanalization of the occluded vessel was assessed in accordance with the modified TICI score, and outcome parameters, including the NIHSS and mRS scores, were documented. Clinical status was recorded after neurointervention, at time of discharge, and after 90 days.
The mean age of all patients was 68 years; 54% were male, with no statistical differences in demographics between both groups. Successful recanalization (TICI 3 and TICI 2b) was achieved in 82% of patients treated with stent retrievers compared with 62% of patients treated with Merci retrievers (P = .016). In the 90-day follow-up, 65% of patients treated with stent retrievers and 35% of those treated with the Merci had achieved a good (mRS = 0-2) clinical outcome (P = .002). Patients treated with stent retrievers had a significantly shorter treatment time (72 versus 122 minutes, P < .01) and less severe intracerebral hemorrhages (10% versus 28%, P < .01).
Patients treated with Trevo and Solitaire stents had a better revascularization rate, better clinical outcome, and lower complication rate than patients treated with the Merci retriever.
大脑动脉闭塞再通是卒中治疗的目标。目前,许多再通装置已在临床应用。本研究比较了新一代支架取栓装置与已确立的 Merci 取栓器的疗效和安全性。
前瞻性登记所有接受血管内机械再通治疗的患者。122 例患者分别采用新的支架取栓器(Trevo 和 Solitaire 装置)或 Merci 取栓器系统治疗。闭塞血管的再通程度按照改良 TICI 评分进行评估,并记录疗效参数,包括 NIHSS 和 mRS 评分。神经介入治疗后、出院时和 90 天后记录临床状况。
所有患者的平均年龄为 68 岁;54%为男性,两组间人口统计学差异无统计学意义。支架取栓组 82%的患者实现了成功再通(TICI 3 和 TICI 2b),而 Merci 组为 62%(P =.016)。90 天随访时,支架取栓组 65%的患者和 Merci 组 35%的患者取得了良好的临床转归(mRS = 0-2)(P =.002)。支架取栓组的治疗时间明显缩短(72 分钟 vs. 122 分钟,P <.01),颅内出血更轻(10% vs. 28%,P <.01)。
与 Merci 取栓器相比,Trevo 和 Solitaire 支架治疗的患者血管再通率更高,临床结局更好,并发症发生率更低。